Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of BioMarin Pharmaceutical Inc.. A complete text table follows the diagram.
Product revenue dominates, with royalties and other revenue as a smaller biotech stream.
Swipe to explore
Labels and displayed flow values are reported filing values or exact disclosed subtotals.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| BioMarin Pharmaceutical Inc. revenue | 1 | $766M | $766.2M reported quarterly revenue |
| Net product revenues | 2 | $760M | 99% of total revenues |
| Royalty and other revenues | 2 | $6.1M | 1% of total revenues |
| From | To | Value |
|---|---|---|
| BioMarin Pharmaceutical Inc. revenue | Net product revenues | $760M |
| BioMarin Pharmaceutical Inc. revenue | Royalty and other revenues | $6.1M |